Rekvina Laboratories Ltd (526075) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 526075 | NSE: | Trading | Small Cap

Rekvina Labs Share Price

4.50 0.00 0.00%
as on 13-Dec'21 18:01

DeciZen - make an informed investing decision on Rekvina Labs

Based on:

M-Cap below 100cr DeciZen not available

Rekvina Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
2.7 Cr.
52-wk low:
4.5
52-wk high:
4.5

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Rekvina Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'24Mar'25TTM
ROCE % 0.8%-10.4%-3.3%-12.6%-30.5%1.7%-51.3%-125.9%0%0%-
Value Creation
Index
-0.9-1.7-1.2-1.9NANANANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00.1000000000
Sales YoY Gr.-100%-100%NANANANANANANA-
Adj EPS 0-0.1-0-0.1-0.40-0.1-0.1-0-0.20
YoY Gr.--1000%NANANANANANANANA-
BVPS (₹) 0.90.80.80.70.30.30.20-0.3-0.60.1
Adj Net
Profit
0-0.1-0-0.1-0.30-0.1-0.1-0-0.10
Cash Flow from Ops. -0-00-00.1-0-0-0-0-0.2-
Debt/CF from Ops. -0.5-0.216.9-8.90000-4.7-1.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%NANANA
Adj EPS -241.7%NANANA
BVPS-194.3%-216.2%-254.2%NA
Share Price -4.5% 1.5% - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'24Mar'25TTM
Return on
Equity %
0.6-10.6-3.9-17.9-89.61.5-51.4-147.81852-0
Op. Profit
Mgn %
15.4-89.900000000-17.9
Net Profit
Mgn %
12.2-90.100000000NAN
Debt to
Equity
000.40.50000-0.2-0.7-
Working Cap
Days
5,0592,549000000009
Cash Conv.
Cycle
-1,342-4,94000000000-86

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Rekvina Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 0.1 -
Reserves (₹ Cr.) -3 -
P/BV 31.29 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 4.50 / 4.50
All Time Low / High (₹) 0.50 / 77.75
Market Cap (₹ Cr.) 2.7
Equity (₹ Cr.) 3
Face Value (₹) 5
Industry PE 34.9

Management X-Ray of Rekvina Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Rekvina Labs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Rekvina Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.06000000000
Operating Expenses 0.120.050.100.130.150.060.0700.020.14
Manufacturing Costs00000.0100000
Material Costs0000000000
Employee Cost 0.010000.0800000.04
Other Costs 0.110.050.100.130.060.060.0700.020.09
Operating Profit -0.06-0.05-0.10-0.13-0.15-0.06-0.07-0-0.02-0.14
Operating Profit Margin (%) -89.9%---------
Other Income 00.030.020.010.1500000
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax -0.06-0.02-0.08-0.120-0.06-0.07-0-0.02-0.14
Tax 0000.13000.01000
Profit After Tax -0.06-0.02-0.08-0.250-0.06-0.08-0-0.02-0.14
PAT Margin (%) -90.0%---------
Adjusted EPS (₹)-0.1-0.0-0.1-0.40.0-0.1-0.10.0-0.0-0.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.500.490.410.150.160.090.010.01-0.20-0.33
Share Capital 3.013.013.013.013.013.013.013.013.013.01
Reserves -2.51-2.53-2.61-2.86-2.86-2.92-3-3-3.21-3.35
Minority Interest0000000000
Debt0.010.170.21000000.040.25
Long Term Debt0000000000
Short Term Debt0.010.170.21000000.040.25
Trade Payables0.130.130.190.140.120.150.180.110.110.11
Others Liabilities 00000000.080.050.01
Total Liabilities 0.640.790.800.290.280.240.190.200.010.03

Fixed Assets

Gross Block0.510.510.510.510.510.510.510.5100
Accumulated Depreciation0.370.370.370.370.370.370.370.3700
Net Fixed Assets 0.150.150.150.150.150.150.150.1500
CWIP 0000000000
Investments 0.050.050.050.050.050.050.050.0500
Inventories0000000000
Trade Receivables0.280.250.260.01000000
Cash Equivalents flag 0.030.130.150.020.01000.010.010.03
Others Assets 0.140.210.200.060.070.05-0000.01
Total Assets 0.640.790.800.290.280.240.190.200.010.03

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.040.01-0.020.08-0.01-0.01-0.040.01-0.01-0.19
PBT -0.06-0.02-0.08-0.120-0.06-0.08-0-0.02-0.14
Adjustment 0000000000
Changes in Working Capital 0.010.030.060.33-0.020.060.040.010.01-0.05
Tax Paid 000-0.13000000
Cash Flow From Investing Activity 0.07-0.0700000.04000
Capex 0000000000
Net Investments 0-0.0700000000
Others 0.07000000.04000
Cash Flow From Financing Activity -00.160.04-0.21-0-0-0-00.010.21
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0-00-0-0-0-0-000
Dividend Paid 0000000000
Others -00.160.04-0.2100000.010.21
Net Cash Flow 0.030.100.01-0.12-0.01-0.01-00.01-00.02

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-10.61-3.89-17.91-89.611.54-51.4-147.84-0.33N/AN/A
ROCE (%)-10.39-3.28-12.59-30.451.73-51.32-125.91-0.1N/AN/A
Asset Turnover Ratio0.1000000000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days1,534000000000
Inventory Days0000000000
Payable Days0000000000

Rekvina Laboratories Ltd Stock News

Rekvina Laboratories Ltd FAQs

The current trading price of Rekvina Labs on 13-Dec-2021 18:01 is ₹4.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Dec-2021 the market cap of Rekvina Labs stood at ₹2.71.
The latest P/E ratio of Rekvina Labs as of 12-Dec-2021 is 0.00.
The latest P/B ratio of Rekvina Labs as of 12-Dec-2021 is 31.29.
The 52-week high of Rekvina Labs is ₹4.50 and the 52-week low is ₹4.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rekvina Labs is ₹0.00 ( Cr.) .

About Rekvina Laboratories Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×